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Abstract
Background: Organ-space surgical site infections (SSI) are the most serious and costly infections after colorectal
surgery. Most previous studies of risk factors for SSI have analysed colon and rectal procedures together. The aim of
the study was to determine whether colon and rectal procedures have different risk factors and outcomes for
organ-space SSI.
Methods: A multicentre observational prospective cohort study of adults undergoing elective colon and rectal
procedures at 10 Spanish hospitals from 2011 to 2014. Patients were followed up until 30 days post-surgery.
Surgical site infection was defined according to the Centers for Disease Control and Prevention criteria. Oral
antibiotic prophylaxis (OAP) was considered as the administration of oral antibiotics the day before surgery
combined with systemic intravenous antibiotic prophylaxis.
Results: Of 3,701 patients, 2,518 (68%) underwent colon surgery and 1,183 (32%) rectal surgery. In colon surgery,
the overall SSI rate was 16.4% and the organ-space SSI rate was 7.9%, while in rectal surgery the rates were 21.6%
and 11.5% respectively (p < 0.001). Independent risk factors for organ-space SSI in colon surgery were male sex
(Odds ratio -OR-: 1.57, 95% CI: 1.14–2.15) and ostomy creation (OR: 2.65, 95% CI: 1.8–3.92) while laparoscopy
(OR: 0.5, 95% CI: 0.38–0.69) and OAP combined with intravenous antibiotic prophylaxis (OR: 0.7, 95% CI: 0.51–0.97)
were protective factors. In rectal surgery, independent risk factors for organ-space SSI were male sex (OR: 2.11, 95%
CI: 1.34–3.31) and longer surgery (OR: 1.49, 95% CI: 1.03–2.15), whereas OAP with intravenous antibiotic prophylaxis
(OR: 0.49, 95% CI: 0.32–0.73) was a protective factor. Among patients with organ-space SSI, we found a significant
difference in the overall 30-day mortality, being higher in colon surgery than in rectal surgery (11.5% vs 5.1%, p = 0.04).
Conclusions: Organ-space SSI in colon and rectal surgery has some differences in terms of incidence, risk factors and
outcomes. These differences could be considered for surveillance purposes and for the implementation of preventive
strategies. Administration of OAP would be an important measure to reduce the OS-SSI rate in both colon and rectal
surgeries.
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Background
Due to the clean-contaminated nature of the wound, rates
of surgical site infections (SSI) after colorectal surgery are
the highest among elective procedures, exceeding 20% in
some institutions [1–3]. It has been suggested that the
rates and risk factors for developing an SSI after colon
and rectal surgery may be different [4, 5], due to the differ-
ences found in the surgical approach and the degree of
bacterial contamination between both surgeries. Never-
theless, most studies carried out to date have analysed
colon and rectal surgeries together [6, 7]. Separate assess-
ments of patients undergoing colon and rectal surgery are
scarce [4, 8].
It has been proposed that incisional SSI (I-SSI) and
organ-space SSI (OS-SSI) may have distinct pathogenesis
and risk factors. Incisional SSI has been associated with
increased body mass index or the presence of an ostomy
[6, 9]. On the other hand, OS-SSI has been more fre-
quently related to blood transfusion, previous abdominal
surgery or poor nutritional status [6, 7, 10]. Interestingly,
the development of an OS-SSI has more severe conse-
quences than the development of an I-SSI; in many cases
OS-SSI requires reoperation and increases morbidity
and length of stay (LOS) [11, 12]. Moreover, while many
of the most significant advances in colon and rectal sur-
gery such as laparoscopy and other minimally invasive
techniques have decreased I-SSI rates, they have had a
lesser impact on OS-SSI [13, 14].
Remarkably, the administration of mechanical bowel
preparation (MBP) was discontinued in the last decades
in most Spanish hospitals due to the lack of effectiveness
[15]. In this scenario, and for reasons not well estab-
lished, the administration of oral antibiotic prophylaxis
(OAP) was discontinued too. Currently, only some
hospitals use it in the elective surgery of the colon and
rectum in Spain. This situation contrasts with that of
other European and American countries, where the
OAP is part of the daily practice.
The aim of this study was to compare the incidence,
risk factors and outcomes of OS-SSI in patients under-
going elective surgery of the colon or rectum in a large,
representative cohort of Spanish hospitals.
Methods
Patients, design and setting
We performed a multicentre observational study of a
prospective cohort of adult patients (≥18 years old)
undergoing elective colon and rectal surgery from January
2011 to December 2014 at 10 hospitals participating in the
VINCat program. All consecutive patients hospitalized in
any surgical department at the different hospitals were in-
cluded and followed up until 30 days after surgery. Patients
with a pre-existing SSI at the time of surgery were ex-
cluded. Post-discharge surveillance of SSI was mandatory
and consisted of a review of electronic clinical records
(primary and secondary care), checking readmissions and
emergency visits, and reviewing microbiological and radio-
logical data. For the purposes of the present study, patients
were differentiated according to whether colon or rectal
surgery was performed.
VINCat surveillance program
The VINCat program [16] is a healthcare-associated infec-
tion surveillance program in Spain, based on the National
Healthcare Safety Network (NHSN) model [17]. It recruits
hospitals on a voluntary basis and currently receives
surveillance data from trained infection control staff at 66
hospitals, who submit information on preoperative demo-
graphics, comorbidities, operative characteristics, micro-
biology and treatment data, and 30-day postoperative
outcomes for eligible surgical procedures [18].
Definitions
SSIs were defined according to the Centers for Disease
Control and Prevention (CDC) criteria [19] and divided
into superficial incisional, deep incisional and OS. Surgical
procedure categories were stratified according to the risk
of surgical infection (−1 to 3) as defined by the NHSN.
Independent variables
Predictor variables considered for the development of an
OS-SSI were: age, sex, American Society of Anesthesiol-
ogists (ASA) physical status classification, MBP, OAP,
adequacy of intravenous antibiotic prophylaxis, surgical
risk index category according to the National Nosoco-
mial Infections Surveillance (NNIS) modified system
criteria [20], date and prolonged operation time (≥75th
percentile of the procedure), laparoscopy, wound classifi-
cation, date of SSI, site of SSI (I-SSI or OS-SSI), microbiol-
ogy and underlying disease (neoplasia, inflammatory
bowel disease –IBD- or others). Age (<65 and ≥ 65 years),
ASA (I-II and III-IV) score and NNIS modified risk index
(−1-0 and 1–2) were dichotomized for the analysis.
Adequacy of intravenous antibiotic prophylaxis was
established when all the following three factors were
met: antibiotics administered according to local protocol
at each hospital, completion of the infusion within
60 min before the surgical incision, and perioperative
antibiotic redosing if indicated.
The OAP was always considered as the administration of
oral antibiotic prophylaxis the day before surgery in com-
bination with systemic intravenous antibiotic prophylaxis
perioperatively. The administration was not mandatory and
was done according to local protocols at each hospital. It
was applied in 4 of the 10 participating hospitals.
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Dependent variables
The development of overall SSI and OS-SSI in both
colon and rectal populations, readmission, LOS and
mortality within 30 days of initial surgery were recorded.
Readmission for any cause within 30 days of initial sur-
gery was documented. LOS included readmission if
there was. Overall mortality was defined as death due to
any cause within 30 days of initial surgery.
Statistical analysis
Categorical variables were described as totals and fre-
quencies; continuous variables were described as me-
dians and interquartile ranges (IQR) and mean and
standard deviation (SD) in some cases. Univariate
analysis comparing the two populations was carried
out using the chi-square test or Fisher exact test for
categorical variables and the t-test or Mann-Whitney
test for continuous variables. Comparisons between
patients who developed an OS-SSI and those who did
not (no OS-SSI) were performed separately for colon
and rectal populations. Finally, multivariate analysis
with all statistically significant variables (p ≤ 0.05)
associated with OS-SSI in colon and rectal popula-
tions were performed separately to determine inde-
pendent predictive factors for the development of
OS-SSI. In these cases, results were given as odds
ratios (OR) and 95% confidence intervals (95% CI).
The final model’s goodness-of-fit was assessed by the
Hosmer-Lemeshow test. Data were analysed with IBM
SPSS 20.0 (Chicago, Ill.).
Results
Characteristics of patients and incidence of SSI in colon
and rectal surgery
During the study period, a total of 3,701 patients under-
going elective colorectal surgery were prospectively
followed-up, 68% after colon surgery and 32% after
rectal surgery.
Characteristics of patients undergoing colon or rec-
tal surgery are shown in Table 1. Patients who under-
went colon surgery were older (median age 70.6 years,
interquartile range [IQR] 62–79 vs 68 years [IQR 60–76],
p < 0.001) and had higher proportions of ASA score III-IV
(42.2% vs 36.7%, p = 0.002) than patients undergoing rectal
surgery. In contrast, patients undergoing rectal procedures
were more likely to be male (67.2% vs 59.3%, p = 0.001), to
have neoplasia (97% vs 93.5%, p < 0.001), to have a lon-
ger duration of surgery (42.7% vs 37.6%, p = 0.003), and
to have an ostomy (64% vs 8.3%, p < 0.001). The admin-
istration of correct intravenous antibiotic prophylaxis
was 84% in colon surgery and 81.6% in rectal surgery,
p = 0.4. In colon surgery, the overall SSI rate was 16.4%
and the OS-SSI rate 7.9%, while in rectal surgery, the
overall SSI was 21.6% and the OS-SSI 11.5% (p < 0.001),
as shown in Fig. 1. When patients who received OAP
combined with correct intravenous antibiotic prophy-
laxis (n = 1.345) were analysed, significant differences in






Age, median (IQR) years 70.6 (62–79) 68 (60–76) <0.001
Age ≥65, n (%) 1711 (67.95%) 724 (61.20%) 0.001
Males, n (%) 1494 (59.33%) 795 (67.20%) 0.001
ASA III-IV, n (%) 1062 (42.18%) 434 (36.69%) 0.002
Neoplasia, n (%) 2355 (93.5%) 1147 (97%) <0.001
Inflammatory bowel disease, n (%) 75 (3%) 16 (1.4%) 0.003
Other, n (%) 86 (3.4%) 17 (1.4%) 0.001
Duration of surgery ≥75th-percentilea, n (%) 947 (37.61%) 505 (42.69%) 0.003
NNIS Risk index 1–2, n (%) 909 (36.10%) 398 (33.64%) 0.15
Laparoscopy, n (%) 1515 (60.17%) 782 (66.10%) 0.001
Correct IV antibiotic prophylaxis, n (%) 2117 (84.07%) 966 (81.66%) 0.41
Previous radiotherapy, n (%) 33 (1.31%) 545 (46.07%) <0.001
Previous chemotherapy, n (%) 78 (3.10%) 533 (45.05%) <0.001
Oral antibiotic prophylaxis, n (%) 1078 (42.81%) 489 (41.34%) 0.41
Mechanical bowel preparation, n (%) 1749 (69.46%) 1038 (87.74%) <0.001
- Missing 58 (2.30%) 20 (1.69%)
Ostomy, n (%) 208 (8.26%) 754 (63.74%) <0.001
IQR interquartile range, ASA American Society of Anesthesiologists physical status classification, NNIS National Nosocomial Infections Surveillance, IV intravenous
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
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overall SSI rate between colon and rectal surgery (12.3%
vs 19.9%, p < 0.001) were found, while there were no
differences in the OS-SSI rate (6.2% vs 8.4%, p = 0.1).
Risk factors for OS-SSI in colon and rectal surgery
Univariate analyses of risk factors for OS-SSI in colon
and rectal surgery are shown separately in Table 2. In
colon surgery, male sex, NNIS ≥1 and ostomy creation
were significantly associated with OS-SSI, while laparo-
scopic surgery and OAP had lower associations with
OS-SSI. In rectal surgery, male sex, longer duration of
surgery and NNIS ≥1 were associated with OS-SSI,
whereas OAP had a lower association with OS-SSI.
A logistic regression multivariate analysis using signifi-
cant predictive factors found in the univariate analysis is
shown in Table 3. Independent risk factors for OS-SSI
after colon surgery were male sex (OR 1.57, 95% CI 1.14–
2.15) and ostomy creation (OR 2.65, 95% CI 1.8–3.9),
while laparoscopy (OR 0.5, 95% CI 0.38–0.69) and the
administration of OAP (OR 0.7, 95% CI 0.51–0.97) were
independent protective factors. Independent risk factors
for OS-SSI in rectal surgery were male sex (OR 2.11,
95% CI 1.34–3.31) and longer duration of surgery
Fig. 1 Incidence of surgical site infection in colon and rectal surgery. Shows the incidence of overall surgical site infection, incisional surgical site
infection and organ-space surgical site infection in colon and rectal surgery separately. SSI: surgical site infection
Table 2 Univariate analysis of risk factors for organ-space surgical site infection in colon and rectal surgery
Colon Rectum
Risk factor No OS-SSI (n = 2318) OS-SSI (n = 200) p- value No OS-SSI (n = 1043) OS-SSI (n = 136) p- value
Age, median (IQR) years 70 (61–79) 73 (63–79) 0.3 68 (60–76) 66.5 (58–74) 0.07
Age≥ 65 years, (%) 67.6 72 0.2 61.5 58.8 0.5
Male sex, (%) 58.4 70 0.001 65.4 80.9 <0.001
ASA≥ III, (%) 41.9 45.5 0.3 36.1 41.2 0.25
Correct IV antibiotic prophylaxis, (%) 84.3 81.5 0.3 81.4 83.8 0.5
Duration of operation≥ p75tha, (%) 37.5 39 0.7 41.2 54.4 0.003
Laparoscopy, (%) 61.6 44 <0.001 66.3 64.7 0.7
NNIS≥ 1, (%) 35.5 43 0.03 32.7 41.2 0.05
Neoplasia, (%) 93.6 93 0.7 97.2 94.9 0.13
Inflammatory bowel disease, (%) 2.9 4 0.38 1.1 2.9 0.1
Chemotherapy, (%) 3.1 3.5 0.7 45.1 45.2 1
Radiotherapy, (%) 1.2 2.5 0.18 46 47.4 0.7
Oral antibiotic prophylaxis, (%) 43.7 33 0.004 43.3 26.5 <0.001
Mechanical bowel preparation, (%) 71.4 67.2 0.2 89.1 90.4 0.6
Ostomy, (%) 7.3 20 <0.001 63.8 65.2 0.7
No OS-SSI no organ-space surgical site infections (include patients with incisional SSI and patients without SSI), OS-SSI organ-space SSI, IQR interquartile range, ASA
American Society of Anesthesiologists physical status classification, IV intravenous, NNIS National Nosocomial Infections Surveillance Risk Index.
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
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(OR 1.49, 95% CI 1–2.15), whereas the administration
of OAP (OR 0.49, 95% CI 0.32–0.73) was the only
independent protective factor.
Outcomes of patients with OS-SSI in colon and rectal surgery
Table 4 shows the outcomes of patients who developed
an OS-SSI in colon and rectal surgery. There were no
significant differences between colon and rectal proce-
dures regarding median LOS (25 days [IQR 18–31] vs
23 days [IQR 16–33], p = 0.1), mean LOS (30.2 days ±
SD 25 vs 32 days ± SD 28, p = 0.19) and readmission rate
(19.5% vs 24.3%, p = 0.3). Overall 30-day mortality was
significantly higher after colon surgery than after rectal
surgery (11.5% [23/200] vs 5.1% [7/136], p = 0.04).
Discussion
This large multicentre cohort study found significant
differences in the incidence, predictive factors and out-
comes of OS-SSI after elective colon and rectal surgery.
This suggests that the two procedures should be consid-
ered as different surgical interventions.
The separation of procedures according to patients’
characteristics may allow more accurate assessment of
their specific risk factors. Comparing colon and rectal
populations, we found that they had different character-
istics in terms of risk factors for SSI. Patients undergoing
colon surgery were older, had more IBD and less lapar-
oscopy, factors related to SSI. On the other hand, pa-
tients undergoing rectal surgery were younger but had
more rate of malignancy; more frequently received
chemoradiotherapy and had longer surgery duration.
The surgical techniques were also different, something
inherent to the anatomical location of the disease, in
special with more ostomies performed in rectal resec-
tions. These factors, associated with the fact that the rec-
tum has higher bacterial contamination load, conferred
it greater risk of SSI. Accordingly, overall SSI and OS-
SSI rates were higher in rectal surgery than in colon sur-
gery. Although these rates were high, they were similar
to these reported in previous studies [8, 21]. Data from
surveillance systems in Europe an US vary widely [22,
23], being in most cases lower than ours, though post-
discharge surveillance is not always performed.
We found significant differences in the predictive factors
for developing an OS-SSI in colon and rectal surgeries. In
colon surgery, independent risk factors predisposing to
OS-SSI were male sex and ostomy creation, while laparo-
scopic surgery and OAP were protective factors. In rectal
surgery, independent risk factors for OS-SSI were male
sex and longer duration of surgery, whereas OAP was the
only protective factor. Male sex was a common risk factor
for developing OS-SSI in both colon and rectal surgeries;
this association is well established [5, 7, 24], although the
reasons are not known.
Ostomy creation was a strong risk factor for the devel-
opment of OS-SSI in colon surgery but not in rectal
surgery, as previously reported elsewhere [8]. Ostomies
are normally used to divert the faecal stream from a newly
created immature anastomosis, or to definitively discon-
nect the gastrointestinal tract in some extensive colorectal
Table 3 Multivariate analysis of risk factors for organ-space surgical site infection in colon and rectal surgery
Colon Rectum
Risk factor OR 95% CI p-value Risk factor OR 95% CI p-value
Male sex 1.57 1.14–2.15 0.004 Male sex 2.11 1.34–3.31 0.001
Laparoscopy 0.5 0.38–0.69 <0.001 Duration of operation≥ p75tha 1.49 1.03–2.15 0.07
NNIS≥ 1 1.17 0.83–1.64 0.36 NNIS≥ 1 1.1 0.74–1.66 0.6
Oral antibiotic prophylaxis 0.7 0.51–0.97 0.03 Oral antibiotic prophylaxis 0.49 0.32–0.73 0.001
Ostomy 2.65 1.8–3.92 <0.001
Signifficant OR and 95% CI appear in bold text
OR Odds ratio, 95%CI 95% confidence interval, NNIS National Nosocomial Infections Surveillance Risk Index.
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
Table 4 Outcomes of patients with organ-space surgical site infection in colon and rectal surgery
Variable Colon (n = 200) Rectum (n = 136) Overall (n = 336) p-value
Readmission, n (%) 39 (19.5) 33 (24.3) 72 (21.4) 0.3
Readmission due to SSI, n (%) 34 (17) 30 (22.1) 64 (19) 0.2
Length of stay, median (IQR) days 25 (18–31) 23 (16–33) 24 (17–36) 0.1
Length of stay, mean (SD) days 30.2 (25) 32 (28) 27.6 (19.7) 0.1
Mortality, n (%) 23 (11.5) 7 (5.1) 30 (8.9) 0.04
Mortality attributed to SSI, n (%) 21 (10.5) 6 (4.4) 27 (8) 0.04
SSI surgical site infection, IQR interquartile range, SD standard deviation
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surgeries. Nevertheless, ostomies have been associated
with increased rates of SSI in previous studies [4–6, 9] be-
cause they allow organisms from the air, contaminated
hands, or skin flora to reach the subcutaneous fat and the
wound, and eventually the intraabdominal cavity [25]. In
our study, patients with colon surgery who received an os-
tomy more frequently underwent laparotomy due to com-
plex pathology like IBD or diverticulitis. These diseases
have been associated with OS-SSI [26], and ostomy cre-
ation may act, in part, as a marker of this complex
pathology.
The laparoscopic approach significantly reduced SSI
rates in several large-database studies and also offered
other benefits such as faster recovery of pulmonary func-
tion, less pain and shorter postoperative stay [13, 14]. In
our study it served as an independent protective factor for
the development of OS-SSI in colon surgery, but not in
rectal surgery. Probably, the beneficial effect of laparos-
copy was exceeded by the higher frequency of risk factors
for SSI inherent in rectal surgery.
Importantly, we found that OAP was a protective fac-
tor for the development of OS-SSI in both colon and
rectal surgeries, although the impact was higher in rectal
surgery, probably because the rectum has a higher level
of bacterial contamination. During the study period
there was not a national or regional recommendation for
the application of OAP, and for this reason the use of
the measure was decided by each participating hospital
(it was only applied in 4 of the 10 hospitals). The find-
ings of the present study lead to a change in the clinical
practice of hospitals participating in the VINCat pro-
gram and in 2016 the use of OAP was institutionally
recommended. The OAP combined with intravenous
prophylaxis and MBP significantly reduces SSI rates after
colon and rectal surgery by decreasing the intraluminal
bacterial load [27–30]; in a previous meta-analysis of
randomized controlled trials comparing the effectiveness
of OAP plus intravenous antibiotic prophylaxis vs intra-
venous antibiotic prophylaxis alone, the association of
OAP was estimated to reduce the incidence of SSI by
43% [31]. Nevertheless, the use of MBP has been widely
questioned, due to its unpleasant gastrointestinal effects,
and in many studies it has failed to reduce SSI rates
[15]. Currently, since almost all studies that demonstrate
the effectiveness of OAP have been performed in combin-
ation with MBP, the use of MBP will have to be raised
again. Last World Health Organization (WHO) recom-
mendations on preoperative measures for surgical site
infection prevention suggest using OAP with MBP in all
adults undergoing elective colorectal surgery [32, 33].
Longer duration of surgery was an independent risk
factor for the development of an OS-SSI in rectal sur-
gery. This association has often been described in the
colorectal surgery population [21, 34, 35], and it also
favours other risk factors for SSI like the hyperglycaemia
or hypothermia [33]. Given the capacity of this param-
eter to predict SSI, it was included as one of the compo-
nents of the NNIS risk index. Rectal tumours close to
the anal verge usually require extensive surgery with
additional organ resection, requiring longer operative
time and causing greater bleeding, factors that have been
associated with an increased risk of SSI [24, 36]. More-
over, in these prolonged surgeries, antibiotic redosing is
not always administered correctly.
Significantly, mortality of patients with OS-SSI after
colon surgery was higher than after rectal surgery. The
fact that patients in the colon group were older and
more frequently had complicated diseases other than
neoplasia could explain this result.
Among the strengths of the study is its multicentre na-
ture, the large number of patients included and the fact
that all data were collected by trained infection control
staff. However, the study has a number of limitations
that should be acknowledged. Firstly, the retrospective
analysis of prospectively collected data may lead to bias
and is unable to control for confounding factors.
Secondly, certain risk factors that have been linked to
SSI such as perioperative hyperglycaemia, hypothermia
and blood transfusion were not recorded here.
Conclusions
We found differences in the incidence, risk factors and
outcomes of overall SSI and OS-SSI between colon and
rectal surgery, suggesting that they could be considered as
different surgical procedures. These differences should be
borne in mind for the purpose of surveillance and for the
implementation of preventive strategies. Administration
of OAP would be an important measure to reduce the
OS-SSI rate in both colon and rectal surgeries.
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